Series A - Science 37

Series A - Science 37

Investment Firm

Overview

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Announced Date

Oct 20, 2015

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Lux Capital

Lux Capital

Lux Capital is a debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

dRx Capital

dRx Capital

dRx Capital is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Participant Investors

3

Investor Name
Participant InvestordRx Capital
Participant InvestorArthur Iinuma
Participant InvestorLux Capital

Round Details and Background

Science 37 raised $6500000 on 2015-10-20 in Series A

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 07, 2021
Post-IPO Equity - Science 37
14-200.0M
Apr 25, 2017
Series C - Science 37
7-35.0M
Oct 18, 2016
Series B - Science 37
5-31.0M
Oct 20, 2015
Series A - Science 37
3-6.5M

Recent Activity

There is no recent news or activity for this profile.